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Background: Health-service evaluation studies are fundamental for proposing interventions and ensuring
improvements in healthcare quality. The present study assesses the performance of health services for indigenous
and non-indigenous populations with regard to tuberculosis (TB) control.
Methods: Interviews with TB patients who underwent treatment between 2009 and 2011 were conducted using
the Primary Care Assessment Tool adapted for TB care in Brazil.
Results: Primary healthcare (PHC) was the first treatment for most patients at symptom onset, and the diagnoses
were typically performed by specialized services. Many patients experienced delayed TB diagnoses that required
more than three medical appointments (51% and 47% for indigenous and non-indigenous populations, respectively).
Indigenous people received social support, such as basic-needs grocery packages (2.19 ± 1.63 vs. 1.13 ± 0.49 for
non-indigenous people, p < 0.01) and home visits from health professionals, with an emphasis on the performance
of directly observed treatment strategies (DOT; 4.57 ± 0.89 vs. 1.68 ± 1.04 for non-indigenous people, p < 0.01).
Conclusions: Regardless of the differences between indigenous and non-indigenous populations, the time
needed to receive a TB diagnosis was unsatisfactory for both groups. Furthermore, DOT must be performed with
better coverage among non-indigenous patients.
Keywords: Tuberculosis, Indigenous, Prevention, Control, Health servicesBackground
Tuberculosis (TB) is a worldwide health problem. One-
third of the world’s population may be infected with
Mycobacterium tuberculosis. Brazil is among the 22
countries with the highest incidence of TB, with a rate
of 43 cases per 100,000 inhabitants in 2010 [1]. In the
world and in Latin America, studies show a high inci-
dence of TB in indigenous populations, exceeding that
of the general population [2-7].
Since 1998, TB control has been the responsibility of
Brazil’s primary healthcare [8]. The decentralization
strategy aims to offer health services related to disease
diagnosis and to institute the DOT for all TB patients* Correspondence: juliocroda@ufgd.edu.br
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reproduction in any medium, provided the or[9,10]. In recent years, many efforts have been made to
increase the coverage of Primary Health Care (PHC).
Although 50% of Brazilians have coverage for primary
care [11], the majority of diagnoses of tuberculosis are
performed in the emergency department or in secondary
and tertiary hospitals [12,13]. PHC presents the longest
time to diagnosis and the lowest proportion of diagnoses
[14]. In addition, increased coverage does not result in an
improvement in the success rate of treatment [15].
Operational studies are important because they pro-
vide information that may help services focus their prac-
tice more precisely and efficiently [16]. Although several
studies have evaluated health services for tuberculosis
control in Brazil [12-14,17-19], no study has evaluated
the decentralization of healthcare in the context of the
indigenous population.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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mined by the National TB Control Program and includes
the largest indigenous population of the State of Mato
Grosso do Sul with a high incidence of TB. The incidence
of TB in the urban population of Dourados is 44 cases per
100,000 inhabitants, and the incidence among the indigen-
ous people of this municipality is even higher, at 230 per
100,000 inhabitants [20].
Before 2000, TB treatment for indigenous patients was
hospitalization for several months, and the default rate was
20% [21,22]. Croda et al. [20] retrospectively evaluated the
performance of health services for this population and
found that with the implementation of the Directly Ob-
served Treatment Strategy (DOTS), there was a consider-
able reduction in default to treatment of 2%. However, this
study has some limitations and potential confounding
factors. The secondary database is also used for epidemio-
logical surveillance; therefore, the results found in this
study are limited by the absence of important variables
related to treatment default, as described in the literature,
such as social characteristics, smoking, malnutrition, hous-
ing conditions, intravenous drug use, socioeconomic status,
and access to health services. Another relevant limitation is
the incompleteness of some of the information, such as the
number of medical appointments and the time required to
establish the diagnosis of tuberculosis.
To clarify these initial findings, a cross-sectional study
was proposed to evaluate the performance of two differentFigure 1 Map of Localization of Dourados, Brazil.TB control programs (indigenous and non-indigenous) in
Dourados using a standardized tool to evaluate the per-
formance of health services.
Methods
Study design and sample
This cross-sectional study was conducted in Dourados,
Mato Grosso do Sul (MS). This city has 196,035 inhabi-
tants, including 12,602 indigenous people (Guarani-Kaiowá
ethnicity) who reside in the indigenous reserves of Bororó
and Jaguapiru, the second largest indigenous population of
the country.
Dourados serves as a reference for 34 cities in the
South region of the state in terms of healthcare, agricul-
ture, and trading (Figure 1).
Regarding the organization of care for TB, two models
of care are identified at the study site. The Municipal
Secretary of Health cares for the non-indigenous popula-
tion, including primary care centers, specialized centers,
and University Hospital. For the Indians, the Special
Indigenous Health Agency (SESAI) is responsible for
the management of a health and tuberculosis control
program that manages the diagnosis and treatment of
TB and notifies the Information System for Notifiable
Diseases (SINAN) about TB infections in this population.
The diagnosis of TB is accomplished by smear, culture,
and X-rays [23]. The BHU offers pots for indigenous
people to collect sputum and directs patients to the
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and bacteriological examinations. Smear sputum micros-
copy of non-indigenous patients is performed by the
laboratory of the municipal Department of Health, and
patients are referred to specialized centers and Univer-
sity Hospital for X-rays.
The sample size required for the T-test was 49 patients,
calculated using Statistica software (using the commands
two means, t-Test, Ind. Samples); mu1 = 2; mu = 3; sigma =
1.5; probability of type I error = 0.05; and power 0.9.
The inclusion criteria were diagnosis with TB by the
Notifiable Diseases Information System (Sistema de
Informação de Agravos e Notificação; SINAN) and
residence in Dourados during treatment between June
1, 2009 and July 31, 2011. Prisoners and patients with
diagnosis changes were excluded from this study. Study
attrition was due to patients who chose not to participate
and those who died or abandoned treatment prior to the
interview.
Medical students received specific training, including
a detailed description of the study and examples of
interviewing techniques. They collected data during two
periods: in the first month for the collection of sociode-
mographic and economic data and in the sixth month
for the evaluation of health services data. Both data sets
were collected at the patients’ homes after obtaining
informed consent and explaining the purpose of the
study.
Indigenous health workers were present at all of the
interviews conducted in the indigenous communities.
These employees helped search for households, intro-
duced the study staff, and translated when necessary.
Data collection tool
The instrument includes questions to elicit sociode-
mographic, clinical, and epidemiologic information, the
location and type of treatment, and specific questions
for each PHC component. The Primary Care Assessment
Tool (PCAT) [24] was adapted, validated, and trans-
ferred by Villa and Ruffino Neto (2009) [25]. The PCAT
is the only instrument that has been translated and vali-
dated to assess health services for TB control in Brazil.
Therefore, it was chosen despite cultural barriers related
to the indigenous population. The PCAT is divided into
three sections.
I. “Access”, which is divided into the categories “access
to diagnosis” and “access to treatment”, includes the
locations of the basic health units (BHUs), the hours/
days that they are open, their degree of tolerance for
unscheduled consultations, and the extent to which the
population perceives that the access is convenient [26].
II. “Bond” measures the existence of a regular source of
care and use over time [26].III. “List of services” assesses arrangements for the
patient to receive any type of required healthcare
service [26].
The respondent (or legal representative) answered
each question on the form using a five-point Likert
scale.
Data analysis
The variables were entered twice into the Epi-Data pro-
gram database, Version 3.0 and were analyzed using the
Statistical Analysis Software Version 9.1 (SAS Institute
Inc., Cary, NC, USA). The double entry of the question-
naire identified mistakes in typing.
Frequency and mean distributions were used to de-
scribe the patients’ sociodemographic and clinical pro-
files. Means and standard deviations of the variables
described using the Likert scale were analyzed and com-
pared using the nonparametric Kruskal-Wallis test.
These averages were evaluated on an intensity scale
from one to five: (1) never, (2) almost never, (3) some-
times, (4) almost always, and (5) always. This order was
reversed if necessary according to the observed variable.
To evaluate the item “home visit”, the average number
of times that health professionals delivered the drug was
used, and the following scale values were assigned: (1)
self-administered, (2) every 15 to 30 days, (3) 1 to 2
times a week, (4) 3 to 4 times a week, and (5) every day.
All inquiries were made to all individuals. The no-answer
condition was assigned a value of zero, “do not know”,
which was not counted in the analysis of each question.
Despite the use of the Kruskal-Wallis test when com-
paring the differences between the Likert scales, the re-
sults were deliberately presented in means and standard
deviations to facilitate the visualization of the data.
Dichotomous and categorical data were analyzed using
the chi-square or Fisher’s exact tests.
The PCAT’s reliability was assessed using its internal
consistency and verified by Cronbach’s alpha. Values be-
tween 0.70 and 0.90 were considered acceptable [27].
Ethical considerations
The Ethics Committee of the Federal University of Grande
Dourados (nº 002/2009) and the National Committee for
Research Ethics/National Health Committee (Comissão
Nacional de Ética em Pesquisa/Conselho Nacional de
Saúde - CONEP/CNS 379 627/09) approved the present
study.
Results
One hundred and eighty-six patients with TB were noti-
fied during the study period, and 46 patients (24.7%)
were excluded for not having a confirmed diagnosis or
being in a seclusion regimen. Among the remaining 140
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locate, 11 died before the end of treatment, and six
patients refused to participate in the study. Four non-
indigenous patients presented treatment default. The
cure rate was 90.6% versus 81.5%, mortality rate 9.3%
versus 6.7% and default rate of 0% versus 5.2% for indi-
genous and urban populations, respectively. Thus, 109
patients constituted the sample evaluation of health
services (Figure 2).
Regarding losses, no significant differences were
found between the two groups. A total of 12 children
required legal representatives to answer the PCAT, in-
cluding 2/52 (3.8%) in the non-indigenous population
and 10/57 (17.5%) in the indigenous population. There
was no difference between those who self-responded
and those who did not. The internal consistency coeffi-
cient (Cronbach’s alpha) ranged from 0.71 to 0.80 for
the Likert scale variables.
Among the 109 patients with TB who were inter-
viewed, men constituted the majority (60%). The indi-
genous patients had a lower mean age, less education,
lower social class, and lower income per capita as well
as more individuals per room compared with non-
indigenous patients. Compared with the indigenous pa-
tients, the non-indigenous patients had higher rates of
alcoholism, drug abuse, and human immunodeficiencyFigure 2 The recruitment of tuberculosis cases.virus/acquired immunodeficiency syndrome (HIV/AIDS)
(Table 1).
Patients with TB in Dourados most often sought
PHC at symptom onset (75% of indigenous patients
and 65% of non-indigenous patients), and their diagno-
ses were primarily performed at specialized services
(60% and 65% for indigenous and non-indigenous pa-
tients, respectively). A delayed diagnosis of TB, which
required more than three medical appointments (46%
for indigenous patients and 44% for non-indigenous
patients) and over five weeks (51% for indigenous pa-
tients and 47% for non-indigenous patients), was found
with regard to both PHC and specialized services. For
indigenous people, home visits by health professionals
were offered more frequently, highlighting the per-
formance of the strategies of directly observed treat-
ment (DOT) (Table 2).
Regarding compliance/bond, the indigenous patients
with TB felt that they were not as well understood
as non-indigenous patients when asking questions
(Table 3).
Fewer indigenous patients had access to HIV/AIDS
testing compared with non-indigenous patients. Further-
more, the indigenous patients were less likely to spend
money to reach the BHUs, and they were treated at the
BHU closest to their homes. Moreover, the indigenous
Table 1 Sociodemographic, economic, clinical, and epidemiologic characteristics of indigenous and non-indigenous




n = 57 n = 52
Sex male 31 (55%) 34 (66%) 0.07
Age, mean ± SD 30.29 ± 25.60 42.02 ± 37.58 <0.011
Have a partner 30 (53%) 21 (40%) 0.05
No education 42 (74%) 14 (27%) <0.01
Monthly income per capita (U.S. dollars), mean ± SD 55.82 ± 61.67 226.8 ± 194.1 <0.011
Social class (ABEP)2, mean ± SD 5.03 ± 4.14 (E) 14.06 ± 5.26 (C2) <0.011
Works at the sugar cane factory 9 (16%) 0 (0%) <0.01
Knows someone with TB 30 (53%) 14 (27%) <0.01
Agglomeration3, mean ± SD 2.23 ± 1.69 0.99 ± 1.67 <0.011
Alcoholism 4/53 (8%) 10 (19%) 0.03
Smoking 49 (86%) 37 (71%) 0.01
Drug abuse 4 (7%) 11 (21%) 0.04
HIV positive 0 (0%) 6 (12%) 0.06
Pulmonary form of TB 51 (90%) 44 (85%) 0.14
Diagnostic
Smear positive 48 (84%) 40/48 (83%) 0.98
Smear negative and culture positive 4/56 (7%) 2/48 (4%) 0.46
1Kruskal-Wallis Test.
2ABEP: Brazilian Association of Research Companies.
3Agglomeration: persons per room.




Initially sought PHC (%) 57 43 (75) 48 31 (65) 0.32
Diagnosis in specialized service (%) 57 34 (60) 48 31 (65) 0.75
Diagnosis time ≥ 5 weeks (%) 53 27 (51) 47 22 (47) 0.69
Number of appointments before diagnosis≥ 3 times (%) 50 22 (46) 48 22 (44) 0.85
Sought health services closer to home? Mean ± SD 57 1.42 ± 1.48 50 2.26 ± 1.71 <0.01*
Waited more than 1 hour to be seen? Mean ± SD 57 2.89 ± 1.99 50 2.40 ± 1.69 0,22*
Had difficulties reaching health services? Mean ± SD 56 3.75 ± 2.14 50 3.70 ± 1.77 0,94*
Spent money on transportation to reach health services? Mean ± SD 57 4.40 ± 1.79 51 3.80 ± 1.76 <0.01*
Missed work or appointments for the medical appointment? Mean ± SD 57 2.82 ± 2.19 51 3.39 ± 1.83 0,10*
Access to treatment
Ability to obtain an appointment in 1 day Mean ± SD 57 3.70 ± 1.96 52 3.82 ± 2.18 0,72*
Underwent TB treatment at the health facility closest to home? Mean ± SD 57 4.28 ± 1.71 52 4.00 ± 1.65 0,11*
How often does a health professional travel to your home to deliver TB medication?† Mean ± SD 56 4.57 ± 0.89 51 1.68 ± 1.04 <0.01*
Access to diagnosis. 1 = always, 2 = almost always, 3 = sometimes, 4 = rarely, and 5 = never. Access to treatment. 1 = never, 2 = almost never, 3 = sometimes,
4 = almost always, and 5 = always.
†1 = Self-administered, 2 = every 15 to 30 days, 3 = 1 to 2 times a week, 4 = 3 to 4 times a week, and 5 = everyday.
*Kruskal-Wallis Test.
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When going to the clinic for a TB consultation, do the same professionals see you? Mean ± SD 56 4.75 ± 0.82 51 4.65 ± 0.88 0.21*
If you have questions about your treatment, are you able to speak with the same
professionals who treat you at the clinic?
Mean ± SD 57 4.63 ± 1.24 51 4.38 ± 1.39 0.26*
After asking a question, do you understand the answer? Mean ± SD 57 4.33 ± 1.27 51 4.70 ± 1.20 0.04*
Do the health professionals at the clinic answer your questions clearly? Mean ± SD 57 4.36 ± 1.35 51 4.76 ± 1.06 0.15*
Do the health professionals at the clinic provide enough time to address your
questions or concerns?
Mean ± SD 57 3.98 ± 1.51 50 4.68 ± 1.13 0.01*
Do the health professionals address your other health problems during the
appointment?
Mean ± SD 57 2.50 ± 1.65 51 2.82 ± 1.92 0.51*
Do the health professionals discuss the TB medication? Mean ± SD 57 4.43 ± 1.29 51 4.23 ± 1.49 0.53*
Do the health professionals ask about all medications that you are taking? Mean ± SD 57 3.31 ± 2.04 51 3.19 ± 1.89 0.85*
What is your opinion of the healthcare team that treats you? Rate them
from 1 to 5.
Mean ± SD 53 4.37 ± 1.16 50 4.50 ± 1.11 0.47*
Do you feel that the healthcare team has any kind of prejudice? (%) 56 (21) 47 (23) 0.81
Compliance/bond. 1 = never, 2 = almost never, 3 = sometimes, 4 = almost always, and 5 = always.
*Kruskal-Wallis Test.
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as basic-needs grocery packages and home visits from
health professionals, when the performance of DOTS
was emphasized compared with non-indigenous patients
(Table 4).
Discussion
Despite the differences between the indigenous and non-
indigenous groups, the time to diagnosis was shown to
be unsatisfactory in both groups. Previous studies have
also found delayed TB diagnoses [28-32]. As a result of
this delay, the risk of transmission and the possibility ofTable 4 List of services for patients in Dourados from June 20
List of services
Does the medical team that accompanies you during TB treatment…
Offer you HIV/AIDS testing?
Offer a flask for sputum examination each month for control of your TB?
Offer monthly consultations for TB treatment and control?
Offer basic-needs grocery packages or food vouchers?
Offer transportation vouchers?
Explain the symptoms of TB?
Explain TB transmission?
Explain TB treatment?
Explain your other health problems?
Conduct home visits for reasons other than TB?
Are the health professionals at the clinic always available when you need the
Are there groups of patients who discuss TB at the clinic where you are bein
List of services. 1 = never, 2 = almost never, 3 = sometimes, 4 = almost always, and
*Kruskal-Wallis Test.death remain high [13]. The evolution to cure was
higher among the indigenous populations (90.6 vs 81.5%,
the mortality rate was similar among indigenous and
urban population (9.3% vs 6.7%). The default rate is 0% in
the indigenous versus 5.2% in the urban populations. This
findings suggesting the superiority of indigenous tubercu-
losis control program related to DOTcovered [10].
Indigenous families are large and have more people
per room than non-indigenous families (2.23 ± 1.69 vs.
0.99 ± 1.67; < 0.01). The size and number of rooms in
the home together with aglomeration are factors that
influence the risk of TB transmission [33] and can be09 to July 2011 (N = 109)
Indigenous Non-indigenous p-value
n n
(%) 53 20 (38%) 45 37 (82%) <0.01
Mean ± SD 57 3.85 ± 1.59 51 3.88 ± 1.70 0.76*
Mean ± SD 55 3.85 ± 1.55 51 3.90 ± 1.59 0.84*
Mean ± SD 57 2.19 ± 1.63 51 1.13 ± 0.49 <0.01*
Mean ± SD 57 1.45 ± 1.51 51 1.11 ± 0.65 0.41*
Mean ± SD 54 3.70 ± 1.75 51 3.54 ± 1.96 0.80*
Mean ± SD 56 3.39 ± 1.73 51 3.76 ± 1.89 0.26*
Mean ± SD 56 4.53 ± 1.06 50 4.26 ± 1.38 0.35*
Mean ± SD 56 2.42 ± 1.80 51 2.33 ± 1.95 0.46
Mean ± SD 56 3.05 ± 1.77 50 2.08 ± 1.53 <0.01*
m? Mean ± SD 57 4.68 ± 1.02 51 4.66 ± 1.69 0.72*
g treated? Mean ± SD 56 4.62 ± 3.75 51 4.80 ± 4.00 0.83*
5 = always.
Lemos et al. BMC Health Services Research 2014, 14:237 Page 7 of 9
http://www.biomedcentral.com/1472-6963/14/237associated with the high incidence of the diseases in the
indigenous populations [20]. The risk of developing TB
in households with four or more people is approximately
three times higher compared to households with two
people or fewer [33]. Recent findings by Welch and
Coimbra Jr. [34], analyzing cultural perspectives of
tuberculosis transmission and treatment among the
Xavante of Mato Grosso State, Brazil support this idea.
In this study, home visits for the treatment of tubercu-
losis occurred less frequently in the non-indigenous
population (4.57 ± 0.89 vs. 1.68 ± 4.1 for non-indigenous
people, p <0.01). A study conducted by Croda et al. [20]
observed lower rates of DOT coverage for this popula-
tion when compared with the indigenous population
(non-indigenous 35% vs. indigenous 92%, p <0.001),
further highlighting the higher default rates (17% vs. 2%;
p <0.001). Amaral et al. [35] evaluated the decentralization
program to control tuberculosis between 2003 and 2006
and found a worsening in the percentage of default (7.7%
to 10.2%) and a significant increase in the percentage of
deaths (3.0% to 15.4%). Despite decentralization, primary
care does not make frequent home visits, which hinders
compliance and the completion of treatment.
The WHO highlights the importance of the organizational
and performance dimensions of healthcare services
(HS), stating that the problem does not lie in detecting
or treating TB, but in how healthcare services are orga-
nized to detect and treat cases of TB [36]. This per-
spective emphasizes the need to expand the diagnosis
of tuberculosis and to offering more X-rays and smears
in primary healthcare. This approach would provide
the opportunity for earlier diagnosis by decreasing the
time to diagnosis and the number of late diagnoses in
emergency and secondary or tertiary services.
Although the majority of patients sought medical
care at the PHC, the current study showed that most
TB diagnoses were performed in emergency depart-
ments and hospitals. The healthcare model found
in the municipality explains this trend because the
Mission Hospital specializes in TB diagnosis among
the indigenous population, whereas University Hos-
pital primarily serves the non-indigenous population.
These findings are similar to several studies conducted
in Brazil [12,13].
Supplying HIV/AIDS exams did not result in satisfac-
tory performance, particularly among the indigenous
population. In Brazil, it is recommended that the investi-
gation of HIV should be supplied to 100% of TB patients
[10]. This exam is performed only in the Sexually Trans-
mitted Diseases reference service, with no corresponding
service in indigenous reserves. The implementation of
rapid HIV testing in primary care service would facilitate
access to the exam, as observed in other studies with
neglected populations [37-39].The indigenous patients felt that they were not as
well understood as the non-indigenous patients when
they asked health questions. Indigenous people con-
sider diseases to be individual, a sign of social or world
disorder, which contradicts the understanding of occi-
dental biomedicine [40]. Sensitivity to the culture and
its conceptions about the health-disease process is
essential for improving the doctor-patient relationship
[41,42].
This study has limitations related to possible sample
selection bias because of participant attrition related to
death and treatment default, which led to the non-
completion of the questionnaire and the exclusion of
data from the analyses. Communication difficulties with
the indigenous community were not reduced even in the
presence of an indigenous health worker. This difficulty
was due to both the low level of education and the lan-
guage barriers, which resulted in a lack of understanding
of certain terms and phrases as well as difficulty in
responding according to the Likert scale. The instrument
is extensive and requires response measures. The appli-
cation of the PCAT for the indigenous population may
not be the best alternative, although it is the only vali-
dated instrument in Brazil for the evaluation of health
services in primary tuberculosis.
Despite these limitations, this study showed that after
operating the decentralization process, there were
improvements in TB control among the indigenous
population, with home visits providing a reduction in
the incidence rate. In the non-indigenous population,
despite decentralization, there is a lack of access to
diagnosis and a need for greater coverage and commit-
ment of health professionals in providing the DOT.
Conclusion
Despite the differences between the indigenous and non-
indigenous groups, the time to diagnosis was shown to be
unsatisfactory in both groups. In particular, the rapid HIV-
AIDS test should be offered through primary healthcare,
especially in indigenous communities. For non-indigenous
people, improvements in access to diagnosis and treat-
ment are necessary, especially with regard to greater
coverage of DOT. Incentives for the strengthening of
primary healthcare with the co-responsibility of other
services may contribute to effective improvements in
TB treatment.
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